VELscope Vx gains European marketing approval
LED Dental’s VELscope Vx oral health screening device has received CE Mark approval. The accreditation certifies that the VELscope Vx has met the health and
LED Dental’s VELscope Vx oral health screening device has received CE Mark approval. The accreditation certifies that the VELscope Vx has met the health and
Tongue cancer survivors experience significant variation in physical and emotional pain during diagnosis and treatment, according to a study to be presented next month at
An 11-year-old New Jersey boy is the most recent winner of the Oral Health America (OHA) National Spit Tobacco Education Program (NSTEP) annual slogan contest.
A U.K. oral health charity has announced the Mouth Cancer Action Month campaign, which will take place throughout November and is dedicated to raising awareness
Aethlon Medical has entered into an agreement with the Sarcoma Oncology Center in Santa Monica, CA, to study the effectiveness of the Aethlon Hemopurifier in
U.S. Rep. Mike Turner (R-OH) is introducing federal legislation that would let the government fine and imprison for up to one year U.S. Department of
Dental professionals in California, take note: New infection-control regulations took effect August 20, and without making some significant changes in certain aspects of your everyday
Two chemists at the University of California, San Diego have discovered the most naturally variable protein known to date in a bacterium that is a
Optical coherence tomography (OCT) offers a noninvasive approach for localizing the most representative site to biopsy in a suspicious oral lesion, according to a study
DentalEZ will conduct free training seminars for customers who have purchased the Identafi oral screening device or are interested in finding out more about the
Four major U.S. tobacco companies have filed a lawsuit against the U.S. Food and Drug Administration (FDA), challenging the agency’s new graphic cigarette warnings as
Curis, a drug company developing next-generation targeted small-molecule drug candidates for cancer treatment, announced that the first patient has been treated in a phase I